Category: Media Coverage

Read the latest news from Beghou Consulting, as well as our experts’ views on trends and challenges in the life sciences industry.

Jon Hesby, Melissa McDevitt and Esin Izat on how to optimize operations after a product’s first birthday

A product’s first birthday offers an ideal time for the commercial team to analyze sales and optimize operations. A year’s worth of sales data and proper computing power enables life sciences companies to examine sales and marketing tactics to see what’s working and what’s not – and then take appropriate action. Jon Hesby, Melissa McDevitt and Esin Izat describe in Pharmaceutical Executive how to enhance sales force effectiveness as part of the post-launch commercialization strategy.
Read More »

Jason Keglovitz describes advantages of Beghou’s Mainsail mobile app

Beghou Consulting’s Mainsail mobile app helps commercial operations teams collect, store and analyze data. The app takes advantage of the device’s native features, including user location for nearby customers and touch screen for signature capture. Jason Keglovitz, lead app developer and software manager, describes to Pharma Tech Outlook how the sales force can benefit from instant access to data and the ability to record customer interactions on the spot.
Read More »

Dan Schulman and Piotr Kula on harnessing digital health data

Digitally-enabled devices will arm medtech companies with more and richer data. To make the best use of this data, companies must build robust and integrated data infrastructures on top of advanced, cloud-based technology. In MD+DI, Dan Schulman and Piotr Kula explain how medtech companies can effectively collect, process, organize and analyze digital health data.
Read More »

Melissa McDevitt on harnessing sales data to maximize commercial success

One year after product launch, pharmaceutical companies have accumulated an abundance of sales-related data. Commercial operations teams can use this data to conduct advanced analytics, identify new targets and transition to a more sustainable incentive compensation plan. Associate Partner Melissa McDevitt shares with PharmaLive how pharmaceutical companies should embrace their sales data to discover new insights and maximize sales beyond the one-year mark.
Read More »

Esin Izat discusses pre-launch marketing research strategies with In Vivo

Emerging pharma companies often encounter resource constraints prior to a product launch, which can lead to commercial challenges. Marketing research can help enhance efficiency and better inform commercial activities. Manager Esin Izat discusses with In Vivo key lessons in marketing research based on her decades of industry experience and how to best implement a marketing research strategy.
Read More »

Esin Izat on marketing research for emerging life sciences companies

Marketing research helps build a product’s competitive advantage, optimizes pricing and payer coverage, and helps to raise investor interest and support. Initiate marketing research early to maximize return on investment, better allocate resources and gain important insights. Manager Esin Izat describes how to design effective marketing research studies in PM360.
Read More »

Emily Eller and Kevin Frymire on pharma’s automation dangers

For pharmaceutical companies, automation of data processes can increase efficiencies, enable close-to-real-time reporting and equip executives to make faster decisions. But just as automation has contributed to disasters in the airline industry, it can pose significant challenges for pharmaceutical commercial teams. Emily Eller and Kevin Frymire explain how to avoid the dangers of automation in Pharmaceutical Executive.
Read More »

Beth Beghou on advanced analytics in incentive compensation

Our 2019 Emerging Pharma Pulse Report describes the importance of using advanced analytics to improve commercial operations and incentive compensation, in particular. Managing Director Beth Beghou describes in MedCity News how emerging pharmaceutical companies that use advanced analytics to decide sales force compensation better retain top performers.
Read More »

Steve Trokenheim on drug pricing transparency in DTC ads

Beginning July 2019, pharmaceutical companies will be required by law to provide the list price of a drug in any DTC television commercial, given the list price is at least $35 for a month’s supply or typical course of treatment. Partner Steve Trokenheim details in PharmaLive how this new regulation improves pricing transparency and requires manufacturers to rethink their approach to setting drug prices.
Read More »